St. Jude Children’s Research Hospital’s new $200-million Global Platform for Access to Childhood Cancer Medicines—a partnership with the World Health Organization—can be traced back to a critique from a visiting reviewer.
“When I was scientific director at St. Jude, I was evaluating the St. Jude International Outreach Program,” St. Jude CEO James Downing said. “I brought in Dr. Tachi Yamada, an expert, to evaluate the program. I had met him at a medical meeting and asked him to help evaluate our international efforts.”
Tadataka “Tachi” Yamada (1945-2021) was a gastroenterologist who was selected in 2006 to serve as executive director of global health for the Bill and Melinda Gates Foundation.
